beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.

Mandyam CD, Altememi GF, Standifer KM. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Eur J Pharmacol. 2000 Aug 18; 402(1-2):R1-37.

View in: PubMed

subject areas

Brain Neoplasms
Brain Neoplasms
Cyclic AMP
Cyclic AMP
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
Humans
Humans
Morphine
Morphine
Naltrexone
Naltrexone
Narcotic Antagonists
Narcotic Antagonists
Narcotics
Narcotics
Neuroblastoma
Neuroblastoma
Opioid Peptides
Opioid Peptides
Receptors, Opioid
Receptors, Opioid
Receptors, Opioid, mu
Receptors, Opioid, mu
Tumor Cells, Cultured
Tumor Cells, Cultured

authors with profiles

Kelly M Standifer